Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiple myeloma in young adults].

O Fernández Ramos, R Trujillo Fernández, M Wilford de León

    Revista Espanola De Oncologia
    |January 1, 1985
    PubMed
    Summary

    This study examines two young patients with multiple myeloma, a rare blood cancer. Their slow-progressing disease and poor response to treatment highlight chemotherapy

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Stem cell implant with neck-head decompression for aseptic necrosis of the femoral head].

    Acta ortopedica mexicana·2014
    Same author

    [Clinico-hematic study of lymphoblastic leukemia of childhood].

    Revista espanola de oncologia·1985
    Same author

    [Chronic pulmonary histoplasmosis. Report of a case].

    Revista cubana de medicina tropical·1985
    Same author

    [Gaucher's disease of an isolated splenic form. Presentation of a patient].

    Revista clinica espanola·1984
    Same author

    [Changes in fibrinolysis in the acute leukemias. A prognostic factor?].

    Revista espanola de oncologia·1981
    Same author

    [Congenital amegakaryocytic purpura with aplasia of the radii report of one case (author's transl)].

    Sangre·1976

    Area of Science:

    • Hematology
    • Oncology

    Background:

    • Multiple myeloma is a cancer of plasma cells.
    • Typical onset is in older adults.

    Observation:

    • Two young patients (27 and 36 years old) presented with unusual multiple myeloma.
    • Both exhibited slow disease progression.
    • Therapy response was poor in both cases.

    Findings:

    • The cases suggest that chemotherapy is most effective for symptomatic and progressive multiple myeloma.
    • Younger age and slow progression may indicate a distinct disease subtype.

    Implications:

    • Further research into distinct multiple myeloma subtypes is warranted.
    • Treatment strategies may need to be tailored based on patient age and disease characteristics.